Literature DB >> 15641006

Cobalamin deficiency and subacute combined degeneration after nitrous oxide anesthesia: a case report.

Sung C Ahn1, Allen W Brown.   

Abstract

We report on a diabetic man in his early forties with a history of disabling left-hemisphere stroke and hyperhomocystinemia who developed new sensorimotor symptoms and urinary incontinence 4 weeks after prolonged exposure to nitrous oxide (N(2)O) related to arterial occlusive disease and amputation. Physical examination at rehabilitation hospital admission showed preexisting severe nonfluent multimodality language impairment, new ataxic quadriparesis superimposed on static spastic right hemiparesis, diffusely blunted muscle stretch reflexes, impaired cutaneous sensation and proprioception, diminished alternating motion rates, and impaired truncal balance. Laboratory tests revealed low serum cobalamin and hyperhomocystinemia. Magnetic resonance imaging of the spinal cord showed dorsal T2-signal hyperintensity. Treatment included vitamin replacement and comprehensive rehabilitation. His response to hospital-based and outpatient treatment led to successful prosthetic fitting. This case shows the importance of screening for and treating cobalamin deficiency before exposing patients with known risk to N(2)O and highlights the potential diagnostic and therapeutic challenges of subacute combined degeneration when it occurs with a setting of preexisting disabling neurologic impairment.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15641006     DOI: 10.1016/j.apmr.2004.01.019

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  9 in total

Review 1.  Potential outcome factors in subacute combined degeneration: review of observational studies.

Authors:  Olavo M Vasconcelos; Erika H Poehm; Robert J McCarter; William W Campbell; Zenaide M N Quezado
Journal:  J Gen Intern Med       Date:  2006-10       Impact factor: 5.128

2.  Nitrous Oxide Toxicity: Case Files of the Carolinas Medical Center Medical Toxicology Fellowship.

Authors:  Kartik Shah; Christine Murphy
Journal:  J Med Toxicol       Date:  2019-08-06

Review 3.  Recreational Nitrous Oxide Abuse: Prevalence, Neurotoxicity, and Treatment.

Authors:  Yuanyuan Xiang; Lei Li; Xiaotong Ma; Shan Li; Yuan Xue; Peng Yan; Meijie Chen; Junwei Wu
Journal:  Neurotox Res       Date:  2021-03-26       Impact factor: 3.911

4.  Inhaled Nitrous Oxide 'Whip-Its!' Causing Subacute Combined Degeneration of Spinal Cord.

Authors:  Mohammed Al-Sadawi; Hidalgo Claris; Chinyere Archie; Apoorva Jayarangaiah; Modupe Oluya; Samy I McFarlane
Journal:  Am J Med Case Rep       Date:  2018-12-26

5.  Subacute combined degeneration of the spinal cord following recreational nitrous oxide use.

Authors:  Hui Mei Cheng; Jae Hong Park; David Hernstadt
Journal:  BMJ Case Rep       Date:  2013-03-08

Review 6.  The Role of Vitamin B12 in the Management and Optimization of Treatment in Patients With Degenerative Cervical Myelopathy.

Authors:  Aria Nouri; Kishan Patel; Julio Montejo; Rani Nasser; David A Gimbel; Daniel M Sciubba; Joseph S Cheng
Journal:  Global Spine J       Date:  2018-05-17

7.  Clinical epidemiological characteristics of nitrous oxide abusers: A single-center experience in a hospital in China.

Authors:  Yueyue Li; Jing Dong; Ran Xu; Fanfan Feng; Weihao Kan; Hongmei Ding; Xiaolong Wang; Yujie Chen; Xin Wang; Shiguang Zhu; Ruiguo Dong
Journal:  Brain Behav       Date:  2021-11-13       Impact factor: 2.708

8.  Nitrous oxide and vitamin B12 in sickle cell disease: Not a laughing situation.

Authors:  Camille Desprairies; Apolline Imbard; Bérengère Koehl; Mathie Lorrot; Jean Gaschignard; Julie Sommet; Samia Pichard; Laurent Holvoet; Albert Faye; Malika Benkerrou; Jean-François Benoist; Manuel Schiff
Journal:  Mol Genet Metab Rep       Date:  2020-03-17

9.  Isolated cortical vein thrombosis after nitrous oxide use in a young woman: a case report.

Authors:  Mao Liu; Jing Zhang; Bitao Bu
Journal:  BMC Neurol       Date:  2020-10-20       Impact factor: 2.474

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.